FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036045424> ?p ?o ?g. }

• W3036045424 endingPage "e000785" @default.
• W3036045424 startingPage "e000785" @default.
• W3036045424 abstract "Background Small cell lung cancer (SCLC) accounts for 15% of lung cancers, and the primary treatment of this malignancy is chemotherapy and radiotherapy. Delta-like 3 (DLL3) is an attractive target for SCLC immunotherapy since its expression is highly restricted to SCLC with a neglectable appearance on normal adult tissues. In the current study, we aimed to explore the efficacy of DLL3-targeted SCLC immunotherapy via the engagement of T cell. Methods As a proof of concept, we constructed DLL3-targeted bispecific antibody and chimeric antigen receptor (CAR)-modified T cells. In vitro and in vivo tumor-suppression activity of these treatments alone or in combination with a Program Death-1 (PD-1) inhibitory antibody was evaluated. Results In vitro studies showed that both DLL3 bispecific antibody and CAR-T efficiently killed DLL3-positive cancer cells, including the native SCLC cell lines H446, H196, H82, and the artificial A431 cells that were forcefully overexpressing DLL3. In vivo studies in xenograft mouse models demonstrated that both bispecific antibody and CAR-T suppressed the tumor growth, and combination therapy with PD-1 inhibitory antibody dramatically improved the efficacy of the DLL3 bispecific antibody, but not the CAR-T cells. Conclusions Our results demonstrated that DLL3-targeted bispecific antibody plus PD-1 inhibition was effective in controlling SCLC growth." @default.
• W3036045424 created "2020-06-25" @default.
• W3036045424 creator A5005223634 @default.
• W3036045424 creator A5028462736 @default.
• W3036045424 creator A5031701013 @default.
• W3036045424 creator A5037580692 @default.
• W3036045424 creator A5042004280 @default.
• W3036045424 creator A5044371162 @default.
• W3036045424 creator A5081104752 @default.
• W3036045424 creator A5082544334 @default.
• W3036045424 date "2020-06-01" @default.
• W3036045424 modified "2023-10-17" @default.
• W3036045424 title "Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth" @default.
• W3036045424 cites W1822869875 @default.
• W3036045424 cites W2058388773 @default.
• W3036045424 cites W2074552727 @default.
• W3036045424 cites W2418354692 @default.
• W3036045424 cites W2560431464 @default.
• W3036045424 cites W2592173429 @default.
• W3036045424 cites W2608733374 @default.
• W3036045424 cites W2613865741 @default.
• W3036045424 cites W2616637874 @default.
• W3036045424 cites W2620975046 @default.
• W3036045424 cites W2761951023 @default.
• W3036045424 cites W2768936582 @default.
• W3036045424 cites W2770758719 @default.
• W3036045424 cites W2891642986 @default.
• W3036045424 cites W2893960509 @default.
• W3036045424 cites W2897225419 @default.
• W3036045424 cites W2899903837 @default.
• W3036045424 cites W2923229075 @default.
• W3036045424 cites W2937415626 @default.
• W3036045424 cites W2947884940 @default.
• W3036045424 cites W2950836608 @default.
• W3036045424 cites W2964089528 @default.
• W3036045424 cites W2966505016 @default.
• W3036045424 cites W2966667483 @default.
• W3036045424 cites W2966817868 @default.
• W3036045424 cites W2986629061 @default.
• W3036045424 doi "https://doi.org/10.1136/jitc-2020-000785" @default.
• W3036045424 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7304844" @default.
• W3036045424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32554616" @default.
• W3036045424 hasPublicationYear "2020" @default.
• W3036045424 type Work @default.
• W3036045424 sameAs 3036045424 @default.
• W3036045424 citedByCount "39" @default.
• W3036045424 countsByYear W30360454242021 @default.
• W3036045424 countsByYear W30360454242022 @default.
• W3036045424 countsByYear W30360454242023 @default.
• W3036045424 crossrefType "journal-article" @default.
• W3036045424 hasAuthorship W3036045424A5005223634 @default.
• W3036045424 hasAuthorship W3036045424A5028462736 @default.
• W3036045424 hasAuthorship W3036045424A5031701013 @default.
• W3036045424 hasAuthorship W3036045424A5037580692 @default.
• W3036045424 hasAuthorship W3036045424A5042004280 @default.
• W3036045424 hasAuthorship W3036045424A5044371162 @default.
• W3036045424 hasAuthorship W3036045424A5081104752 @default.
• W3036045424 hasAuthorship W3036045424A5082544334 @default.
• W3036045424 hasBestOaLocation W30360454241 @default.
• W3036045424 hasConcept C121608353 @default.
• W3036045424 hasConcept C126322002 @default.
• W3036045424 hasConcept C143998085 @default.
• W3036045424 hasConcept C147483822 @default.
• W3036045424 hasConcept C150903083 @default.
• W3036045424 hasConcept C159654299 @default.
• W3036045424 hasConcept C185592680 @default.
• W3036045424 hasConcept C202751555 @default.
• W3036045424 hasConcept C203014093 @default.
• W3036045424 hasConcept C207001950 @default.
• W3036045424 hasConcept C2776256026 @default.
• W3036045424 hasConcept C2777701055 @default.
• W3036045424 hasConcept C2779399171 @default.
• W3036045424 hasConcept C3875195 @default.
• W3036045424 hasConcept C502942594 @default.
• W3036045424 hasConcept C55493867 @default.
• W3036045424 hasConcept C71924100 @default.
• W3036045424 hasConcept C86803240 @default.
• W3036045424 hasConceptScore W3036045424C121608353 @default.
• W3036045424 hasConceptScore W3036045424C126322002 @default.
• W3036045424 hasConceptScore W3036045424C143998085 @default.
• W3036045424 hasConceptScore W3036045424C147483822 @default.
• W3036045424 hasConceptScore W3036045424C150903083 @default.
• W3036045424 hasConceptScore W3036045424C159654299 @default.
• W3036045424 hasConceptScore W3036045424C185592680 @default.
• W3036045424 hasConceptScore W3036045424C202751555 @default.
• W3036045424 hasConceptScore W3036045424C203014093 @default.
• W3036045424 hasConceptScore W3036045424C207001950 @default.
• W3036045424 hasConceptScore W3036045424C2776256026 @default.
• W3036045424 hasConceptScore W3036045424C2777701055 @default.
• W3036045424 hasConceptScore W3036045424C2779399171 @default.
• W3036045424 hasConceptScore W3036045424C3875195 @default.
• W3036045424 hasConceptScore W3036045424C502942594 @default.
• W3036045424 hasConceptScore W3036045424C55493867 @default.
• W3036045424 hasConceptScore W3036045424C71924100 @default.
• W3036045424 hasConceptScore W3036045424C86803240 @default.
• W3036045424 hasFunder F4320335787 @default.
• W3036045424 hasIssue "1" @default.
• W3036045424 hasLocation W30360454241 @default.

• next